跳至主要内容
临床试验/DRKS00027916
DRKS00027916已完成不适用

Oral surgical procedures and vitamin K antagonists. Treatment quality, complications and medication-related interactions. - MKG_VKA

niklinik Freiburg Klinik für MKG Chirurgie0 个研究点目标入组 207 人开始时间: 2022年1月31日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
207

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 111 Years(—)
性别
All

入选标准

  • Patients aged 18 and over
  • Patients who are anticoagulated with a vitamin K antagonist for a pre-existing condition and require a simple dental surgical procedure (tooth extraction, even if this involves a localized osteotomy or intraoral abscess incision)
  • Inpatient stay to monitor postoperative bleeding or secondary inpatient admission in the event of postoperative bleeding
  • Inclusion period: 01/2018- 12/2020

排除标准

  • Patients younger than 18 years. Other congenital or acquired coagulation disorders (also simultaneously), e.g. B. cirrhosis of the liver, von Willebrandt-Jürgens syndrome, therapy with direct oral anticoagulants (DOAC), sole therapy with platelet aggregation inhibitors. Extensive surgeries in the mouth, jaw and face (e.g. trauma, tumor, metal removal, abscess with extraoral incision), other dental surgical interventions e.g. wisdom tooth osteotomy, cystectomy, dental implantation, augmentation)

研究者

发起方
niklinik Freiburg Klinik für MKG Chirurgie

相似试验

进行中(未招募)
1 期
Administration of low risk oral anticoagulation agents to patients with pre-stage atrial fibrillation for stroke prophylaxis
EUCTR2015-003997-33-PLKompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]2,538
进行中(未招募)
1 期
Administration of low risk oral anticoagulation agents to patients with pre-stage atrial fibrillation for stroke prophylaxisAtrial fibrillation (AF) is one cause of stroke. Stroke rate is increased in patients with atrial high rate episodes (AHRE, an early stage of AF) as well, even if stroke rates are lower when compared to stroke rates in patients with diagnosed AF. Prevention of stroke, systemic embolism or cardiovascular death in patients with AHRE but without diagnosed atrial fibrillation (AF) and in addition at least two stroke risk factors by intake of NOACs shall be investigated.MedDRA version: 23.1Level: LLTClassification code 10003656Term: Atrial arrhythmiaSystem Organ Class: 100000004849
EUCTR2015-003997-33-BGKompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]2,538
招募中
3 期
on-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodesatrial high rate episodes (AHRE)subclinical atrial fibrillation10082206
NL-OMON52989Kompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]75
进行中(未招募)
1 期
Administration of low risk oral anticoagulation agents to patients with pre-stage atrial fibrillation for stroke prophylaxis
EUCTR2015-003997-33-BEKompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]2,538
进行中(未招募)
1 期
Administration of low risk oral anticoagulation agents to patients with pre-stage atrial fibrillation for stroke prophylaxisAtrial fibrillation (AF) is one cause of stroke. Stroke rate is increased in patients with atrial high rate episodes (AHRE, an early stage of AF) as well, even if stroke rates are lower when compared to stroke rates in patients with diagnosed AF. Prevention of stroke, systemic embolism or cardiovascular death in patients with AHRE but without diagnosed atrial fibrillation (AF) and in addition at least two stroke risk factors by intake of NOACs shall be investigated.MedDRA version: 23.1Level: LLTClassification code 10003656Term: Atrial arrhythmiaSystem Organ Class: 100000004849
EUCTR2015-003997-33-NLKompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]2,538